RecruitingNCT06611579
Clinical Study of the inQB8 TTVR System (The MonarQ Study)
AI Description
Prospective, multi-center study to assess safety and performance of the inQB8 MonarQ Tricuspid Valve Replacement System.
- Who can join
- adult, older adult
- Participants
- 50
- Expected completion
- 2030-10-31
- Funded by
- industry
Conditions studied
Tricuspid Valve Regurgitation
What is being tested
- DEVICE: Transcatheter Tricuspid Valve Replacement
What it measures
- Absence of device or procedure related major adverse events, 30 days
- Change in TR grade from baseline, 30 days
Centers Participating
These centers are participating in this study. Reach out to them directly to learn more.
Baylor Scott & White The Heart Hospital – Plano
Plano, TX
Cedars-Sinai Medical Center
Los Angeles, CA
Los Robles Regional Medical Center
Thousand Oaks, CA
Penn Presbyterian Medical Center
Philadelphia, PA
Piedmont Atlanta Hospital
Atlanta, GA
Sandra Atlas Bass Heart Hospital at North Shore University Hospital
Manhasset, NY
Registry entry updated 2026-05-18
Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.
If you would rather we did it with you, call us on (656) 206-4686.